5613294 BASELINE PATIENT CHARACTERISTICS FROM A UK EARLY ACCESS TO MEDICINES SCHEME (EAMS) WITH VOXELOTOR, A HBS POLYMERIZATION INHIBITOR, FOR THE TREATMENT OF HEMOLYTIC ANEMIA DUE...

por Eleftheriou, P., Sharif, J., Kesse-Adu, R., Filian-Gloor, M., Agrawal, A., Barcelos, G., Telfer, P.
Publicado 2023

Risks associated with oral deferiprone in the treatment of infratentorial superficial siderosis

por Sammaraiee, Y., Banerjee, G., Farmer, S., Hylton, B., Cowley, P., Eleftheriou, P., Porter, J., Werring, D. J.
Publicado 2019

S110: ACUTE AND CHRONIC PAIN MANAGEMENT IN SICKLE CELL DISEASE: OUTCOMES OF AN ENGLISH NATIONAL AUDIT.

por Lugthart, S, Kotsiopoulou, S, Luqmani, A, Eleftheriou, P, Drasar, E, Brown, R, Webster, A, Chakravorty, S, Stuart-Smith, S, Velangi, M, Atoyebi, W, Howard, J, Telfer, P
Publicado 2022

5607225 ADDITION OF THERAPEUTIC PLASMA EXCHANGE TO RED CELL EXCHANGE IMPROVES OUTCOMES OF FAT EMBOLISM SYNDROME IN SICKLE CELL DISEASE

por Tsitsikas, D.A., Rowe, S., Bosch, A., Hui, C., Sadasivam, N., Palaskas, N., Pancham, S., Rizvi, S., Taylor, J., Greaves, P., Glenthøj, A., Hoffmann, M., Drasar, E., Eleftheriou, P.
Publicado 2023

5610845 A PHASE 1 STUDY OF CSL888 (HEMOPEXIN) IN ADULT PATIENTS WITH SICKLE CELL DISEASE

por Biemond, B.J., Shore, B.J., Wilson, F., Jochems, J., Lindqvist, L.M., Jung, K., Gentinetta, T., Costin, S., Kato, G.J., Eleftheriou, P., Fok, H., Wahab, E., Leung, P.M., Sharif, J., Boucher, A., Fitzgerald, R., Keese-Adu, R., Azbell, R., Liles, D., Bergmann, S., Lanzkron, S., Gordeuk, V.
Publicado 2023